Search

Your search keyword '"Valérie Dubois"' showing total 205 results

Search Constraints

Start Over You searched for: Author "Valérie Dubois" Remove constraint Author: "Valérie Dubois"
205 results on '"Valérie Dubois"'

Search Results

1. The role of donor hypertension and angiotensin II in the occurrence of early pancreas allograft thrombosis

2. HuMSC-EV induce monocyte/macrophage mobilization to orchestrate neovascularization in wound healing process following radiation injury

3. Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation

4. Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

5. Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants

6. Highly Variable Sialylation Status of Donor-Specific Antibodies Does Not Impact Humoral Rejection Outcomes

7. Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the European Group for Blood and Marrow Transplant Chronic Malignancies Working Party

8. Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party

9. Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Société Francophone d’Histocompatibilité et d’Immunogénétique (SFHI) and Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) analysis

10. Subclinical rejection-free diagnostic after kidney transplantation using blood gene expression

12. Evolution of humoral lesions on follow-up biopsy stratifies the risk for renal graft loss after antibody-mediated rejection treatment

13. Revisiting the changes in the Banff classification for antibody-mediated rejection after kidney transplantation

14. Inverted direct allorecognition triggers early donor-specific antibody responses after transplantation

15. Data-driven Derivation and Validation of Novel Phenotypes for Acute Kidney Transplant Rejection using Semi-supervised Clustering

16. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients

17. Diagnostic performance of kSORT, a blood-based mRNA assay for noninvasive detection of rejection after kidney transplantation: A retrospective multicenter cohort study

18. HLA graph, a free and ready-to-use bioinformatics tool to explore anti-HLA eplets reactivity pattern

19. Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features

20. Humoral Alloreactivity in VCA Recipients: Should We Learn From Our Experience?

21. Data-Driven Chronic Allograft Phenotypes: A Novel and Validated Complement for Histologic Assessment of Kidney Transplant Biopsies

22. Impact of calcineurin inhibitor-free immunosuppression on de novo donor-specific antibody formation in liver transplant recipients

23. Outcome of Liver Transplant Patients With Preformed Donor‐Specific Anti–Human Leukocyte Antigen Antibodies

24. Polyclonal expansion of TCR Vb 21.3 + CD4 + and CD8 + T cells is a hallmark of multisystem inflammatory syndrome in children

25. Allograft recognition by recipient's natural killer cells: Molecular mechanisms and role in transplant rejection

26. Prospective Measures of Adherence by Questionnaire, Low Immunosuppression and Graft Outcome in Kidney Transplantation

27. Définition et standardisation des bilans d’histocompatibilité en fonction du parcours du patient et du type de donneur : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) et de la Société Francophone d’Histocompatibilité et Immunogénétique (SFHI)

28. Polyclonal expansion of TCR Vbeta 21.3

29. Superantigenic TCR Vbeta 21.3 signature in Multisystem Inflammatory Syndrome in Children

30. Characteristics of T- and NK-cell Lymphomas After Renal Transplantation: A French National Multicentric Cohort Study

31. Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated Rejection

32. [Definition and standardization of histocompatibility requests depending on patient course and donor type: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) and the Francophone Society of Histocompatibility and Immunogenetics (SFHI)]

33. Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis

34. De Novo Complement-Binding Anti-HLA Antibodies in Heart Transplanted Patients Is Associated with Severe Cardiac Allograft Vasculopathy and Poor Long-Term Survival

35. La chimiotaxie détourne la réponse cytotoxique des lymphocytes T alloréactifs, conférant une protection à l’endothélium vasculaire au cours du rejet cellulaire

36. Massive clonal expansion of polycytotoxic skin and blood CD8

37. HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation

38. Humoral Alloreactivity in VCA Recipients: Should We Learn From Our Experience?

39. [Relevance of antibodies in hematopoietic stem cell transplantation: Antibodies anti-HLA, anti-platelets, anti-granulocytes, anti-erythrocytes and anti-MICA. Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]

40. [Haploidentical hematopoietic stem cell transplant: How to choose the best donor? Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]

41. Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation

42. Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus host disease in conjunction with the CMV status

43. Prevalence, Risk Factors, and Impact of Donor‐Specific Alloantibodies After Adult Liver Transplantation

44. Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic Syndrome

46. Après traitement d’un rejet humoral aigu, la réalisation d’une biopsie de contrôle permet de stratifier le risque de perte de greffon rénal

47. Corrigendum to Berchtold L, Letouzé E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021;99:671–685

48. Étude du chimérisme après allogreffe de cellules hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

49. Deleterious impact of C3d-binding donor-specific anti-HLA antibodies after pediatric liver transplantation

50. Face Transplantation: Partial Graft Loss of the First Case 10 Years Later

Catalog

Books, media, physical & digital resources